Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § 232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate of Incorporation or Bylaws by: (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § 232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIES, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 2 contracts
Samples: Note and Warrant Purchase Agreement (iRhythm Technologies, Inc.), Note and Warrant Purchase Agreement (iRhythm Technologies, Inc.)
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: «WARRANT_HOLDER» COMPANY: IRHYTHM TECHNOLOGIESBIOCARDIA, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 «DATE» (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 2 contracts
Samples: BioCardia, Inc., BioCardia, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESKNIGHTSCOPE, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1APRIL [__], 2012 2019 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 2 contracts
Samples: Distribution Assignment and Warrant Purchase Agreement (Knightscope, Inc.), Knightscope, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESSUTRO BIOPHARMA, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 2 contracts
Samples: Sutro Biopharma Inc, Sutro Biopharma Inc
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l A-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESSUTRO BIOPHARMA, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 2 contracts
Samples: Sutro Biopharma Inc, Sutro Biopharma Inc
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIES, INC. ROBLOX CORPORATION SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 2 contracts
Samples: Roblox Corp, Roblox Corp
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate 's certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s 's records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s 's records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l A-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: XXXXXXX XXXXXXX COMPANY: IRHYTHM TECHNOLOGIESQUANTENNA COMMUNICATIONS, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1FEBRUARY 3, 2012 2016 (THE “"WARRANT”") AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: FEBRUARY 3, 2016 In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 2 contracts
Samples: Quantenna Communications Inc, Quantenna Communications Inc
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l A-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESVaxxinity, INC. Inc. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1AUGUST 5, 2012 2021 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 2 contracts
Samples: Vaxxinity, Inc., Vaxxinity, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. The undersigned may be required to provide evidence of authority and other documentation upon request by the Warrant Agent, including but not limited to, a signature guarantee from an eligible guarantor institution participating in a signature guarantee program approved by the Securities Transfer Association. (Print name of the warrant Warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT AX-l x INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESCRUSH CAPITAL, INC. SECURITIES: THE WARRANT WARRANTS ISSUED ON NOVEMBER 1, 2012 [INSERT DATE] (THE “WARRANTWARRANTS”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 2 contracts
Samples: Warrant Agreement (Crush Capital Inc.), Warrant Agreement (Crush Capital Inc.)
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § 232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate of Incorporation or Bylaws by: (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § 232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) 50 EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESOPTI-HARVEST, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1______________, 2012 2021 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 2 contracts
Samples: Note and Warrant Purchase Agreement (Opti-Harvest, Inc.), Note and Warrant Purchase Agreement (Opti-Harvest, Inc.)
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate 's certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s 's records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s 's records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l A-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: AIRFIDE NETWORKS COMPANY: IRHYTHM TECHNOLOGIESQUANTENNA COMMUNICATIONS, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1FEBRUARY 3, 2012 2016 (THE “'WARRANT”') AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: _________________________ In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 2 contracts
Samples: Quantenna Communications Inc, Quantenna Communications Inc
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIES, INC. ACTIVIDENTITY CORPORATION SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 [INSERT DATE] (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 2 contracts
Samples: Actividentity Corp, Actividentity Corp
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § 232(e§232( e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate 's certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s 's records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s 's records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l I INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: XXXXXXX XXXXXXX COMPANY: IRHYTHM TECHNOLOGIESQUANTENNA COMMUNICATIONS, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1SEPTEMBER 10, 2012 2015 (THE “"WARRANT”') AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: SEPTEMBER 10, 2015 In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 2 contracts
Samples: Quantenna Communications Inc, Quantenna Communications Inc
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iiiii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iviii) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESCALCIMEDICA, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1[•], 2012 2021 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) THEREOF. DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: CalciMedica, Inc. /DE/
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name signature page follows) For Individuals For Entity’s Name of the warrant holder) (Warrant Holder: Name of Warrant Holder: Signature) (: Signature: Name and title of signatory, if applicable) (Signer: Name of Signer: Address: Title of Signer: Address: Date) (: Date: Fax number) (: Fax number: Email address) (Signature Page to the Notice of Exercise) : Email address: EXHIBIT A-l A-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESCANCER PREVENTION PHARMACEUTICALS, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1JANUARY___, 2012 2016 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l A-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: _____________________________________________________________________________ COMPANY: IRHYTHM TECHNOLOGIESCLOUDASTRUCTURE, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 [INSERT DATE] (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: _____________________________________________________________________________ In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Cloudastructure, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESTRUECAR, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1APRIL 21, 2012 2014 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Warrant (TrueCar, Inc.)
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l A-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESTRUECAR, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER EFFECTIVE AS OF JANUARY 1, 2012 (THE “WARRANT”’) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: TrueCar, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESOUTSET MEDICAL, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1JUNE, 2012 2015 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Outset Medical, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) Exercise EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESORGANOVO HOLDINGS, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 [DATE] (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESKNIGHTSCOPE, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1APRIL 30, 2012 2019 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Knightscope, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESWAGEWORKS, INC. SECURITIES: THE AMENDED AND RESTATED WARRANT ISSUED ON NOVEMBER 1DECEMBER 28, 2012 2009 AND AMENDED AND RESTATED AS OF JULY 30, 2010 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Wageworks, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIES, INC. VIRNETX HOLDING CORPORATION SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1APRIL 29, 2012 2020 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: VirnetX Holding Corp
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: [DV-CPP] COMPANY: IRHYTHM TECHNOLOGIESCANCER PREVENTION PHARMACEUTICALS, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1FEBRUARY __, 2012 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: _______________________________ In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: ____________________________________________ COMPANY: IRHYTHM TECHNOLOGIESLEGION WORKS, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 [INSERT DATE] (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: __________________ In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Legion Works, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESSUN BIOPHARMA, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1MAY 15, 2012 2013 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: _________________________________________________________ In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Agreement and Plan of Merger (Cimarron Medical, Inc.)
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESTRUECAR, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1EFFECTIVE AS OF MAY 2, 2012 2014 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: TrueCar, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESOUTSET MEDICAL, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1JUNE 14, 2012 2016 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Outset Medical, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESBOLT BIOTHERAPEUTICS, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1JULY 26, 2012 2018 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Bolt Biotherapeutics, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware §232(e) of the General Corporation Law § 232(eof the State of Delaware (the “DCGL”), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law DGCL or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation LawDGCL) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § 232XXXX §000. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page 1 Note to the Notice of Exercise) Draft: Include if exercised pursuant to Section 2(a). EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTORB ASSIGNMENT FORM ASSIGNOR: COMPANY: IRHYTHM TECHNOLOGIESBIODELIVERY SCIENCES INTERNATIONAL, INC. SECURITIESWARRANT: THE WARRANT TO PURCHASE SHARES OF COMMON STOCK ISSUED ON NOVEMBER 1, 2012 [Insert applicable Borrowing Date] (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (signature page follows) (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESRIGETTI COMPUTING, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 [ ] (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESFLUIDIGM CORPORATION, INC. A DELAWARE CORPORATION SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1JANUARY 6, 2012 2011 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Security Agreement (Fluidigm Corp)
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) [ (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESPHUNWARE, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1__________, 2012 2017 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Stellar Acquisition III Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESTENON MEDICAL, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1DECEMBER 31, 2012 2020 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Tenon Medical, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESOTONOMY, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 [ ] (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Otonomy, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: ___________________________________________________ COMPANY: IRHYTHM TECHNOLOGIESSUN BIOPHARMA, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1MAY 15, 2012 2013 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: ___________________________ In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Sun BioPharma, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESAUGMEDIX, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1______________, 2012 2019 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Augmedix, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIES, MIROMATRIX MEDICAL INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 [INSERT DATE] (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: ______________________________ In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Miromatrix Medical Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or below(or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l I INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: Axxxxx Xxxxx COMPANY: IRHYTHM TECHNOLOGIESKNIG HTSCOPE, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1MARCH 16, 2012 2018 (THE “"WARRANT”” ) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Knightscope, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESFLUIDIGM CORPORATION, INC. A DELAWARE CORPORATION SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1AUGUST 25, 2012 2009 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Fluidigm Corp
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l A-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: GR MATCH, LLC COMPANY: IRHYTHM TECHNOLOGIESTRUECAR, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1FEBRUARY 25, 2012 2011 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Off Agreement (TrueCar, Inc.)
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESHARPOON THERAPEUTICS, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1JULY 13, 2012 2016 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Harpoon Therapeutics, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESSXXXXX SCIENTIFIC, INC. SECURITIES: THE WARRANT WARRANT, NO. 2013-__, ISSUED ON NOVEMBER 1[______], 2012 2013 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Semler Scientific, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) Exercise EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESORGANOVO, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1SEPTEMBER [__], 2012 2011 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Organovo Holdings, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESMEDAVAIL, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 [●] (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Myos Rens Technology Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIES, INC. TEARLAB CORPORATION SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1OCTOBER 8, 2012 2015 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: TearLab Corp
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESKNIGHTSCOPE, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1JANUARY 16, 2012 2018 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Knightscope, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) )] (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESTRUECAR, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1FEBRUARY 11, 2012 2014 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: TrueCar, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: AS IDENTIFIED ON THE SIGNATURE PAGE HERETO COMPANY: IRHYTHM TECHNOLOGIES, INC. CONTRAFECT CORPORATION SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor investor (the “Investor”) represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: CONTRAFECT Corp
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l I INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANYTxxxxx Xxxxxx COMPANY : IRHYTHM TECHNOLOGIESKNIGHTSCOPE, INCI NC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1December 19, 2012 2017 (THE “"WARRANT”” ) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: 12/18/17 In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Knightscope, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate 's certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s 's records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s 's records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l A-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: Axxxxx Xxxxx COMPANY: IRHYTHM TECHNOLOGIESKNIGHTSCOPE, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 [12/19/17] (THE “"WARRANT”') AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: 12/19/17 In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Knightscope, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESOUTSET MEDICAL, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1JUNE 30, 2012 2017 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) )] (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESTRUECAR, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 122, 2012 2013 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: TrueCar, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l I INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: HONK LLC COMPANY: IRHYTHM TECHNOLOGIESTRUECAR, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1APRIL 29, 2012 2011 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: APRIL 29, 2011 In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Off Agreement (TrueCar, Inc.)
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESTRUECAR, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1FEBRUARY 11, 2012 2014 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: TrueCar, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESAEROHIVE NETWORKS, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 [DATE] (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Aerohive Networks, Inc
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESTRUECAR, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1May 2, 2012 2013 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: TrueCar, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESTRUECAR, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1AUGUST 22, 2012 2013 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: TrueCar, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIES, MIROMATRIX MEDICAL INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 [INSERT DATE] (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: _______________________________ In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Miromatrix Medical Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESGROVE COLLABORATIVE, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 [INSERT DATE] (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Grove Collaborative Holdings, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § 232(e), Limited Liability Company Act the undersigned consents to the delivery of any notice to stockholders members given by the Company under the Delaware General Corporation Law Limited Liability Company Act or the Company’s Certificate Third Amended and Restated LLC Agreement, dated as of Incorporation September 12, 2017, as may be amended from time to time, or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iiiii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iviii) any other form of electronic transmission (as defined in the Delaware General Corporation LawLimited Liability Company Act) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § 232Company. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESPluralsight Holdings, INC. LLC SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1[INSERT DATE], 2012 2018 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Pluralsight, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l A-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: AS IDENTIFIED ON THE SIGNATURE PAGE HERETO COMPANY: IRHYTHM TECHNOLOGIES, INC. CONTRAFECT CORPORATION SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1JUNE [ ], 2012 2015 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor investor (the “Investor”) represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: CONTRAFECT Corp
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l A-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIES, XXX.XXX INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1JUNE 25, 2012 2010 (THE THE. “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: TrueCar, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § 232(e)Law, the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) [SIGNATURE PAGE TO THE NOTICE OF EXERCISE] EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESQ THERAPEUTICS, INC. Inc SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1AUGUST 30, 2012 2011 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: ____________________________ In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Q Holdings, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: _______________________ COMPANY: IRHYTHM TECHNOLOGIESLEGION WORKS, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1, 2012 [INSERT DATE] (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: ___________________________ In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Legion Works, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l B-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESNEXGENT, INC. SECURITIES: THE WARRANT WARRANTS ISSUED ON NOVEMBER 1, 2012 [INSERT DATE] (THE “WARRANTWARRANTS”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Warrant Agreement (NEXGENT Inc.)
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate 's certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s 's records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s 's records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l I INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: Proud Ventures KS, LLC COMPANY: IRHYTHM TECHNOLOGIESKNIGHTSCOPE, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1MARCH 16, 2012 20 18 (THE “"WARRANT”' ) AND THE SECURITIES ISSUED OR ISSUABLE ISSUABL E UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION CONVE RSION OF THOSE SECURITIES) DATE: 3/16/18 In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Knightscope, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l B-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: __________________________________________________________________________ COMPANY: IRHYTHM TECHNOLOGIESM&M MUSIC, INC. INC SECURITIES: SECURITIES: THE WARRANT WARRANTS ISSUED ON NOVEMBER 1, 2012 [INSERT DATE] (THE “WARRANTWARRANTS”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: __________________________________________________________________________ In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: Warrant Agreement (M&m Media, Inc.)
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l A-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESTRUECAR, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1MARCH 12, 2012 2014 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Samples: TrueCar, Inc.
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § §232(e), the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page page to the Notice of Exercise) EXHIBIT A-l INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: COMPANY: IRHYTHM TECHNOLOGIESCANCER PREVENTION PHARMACEUTICALS, INC. SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1MARCH __, 2012 2011 (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
Consent to Receipt of Electronic Notice. Subject to the limitations set forth in Delaware General Corporation Law § 232(e)Law, the undersigned consents to the delivery of any notice to stockholders given by the Company under the Delaware General Corporation Law or the Company’s Certificate certificate of Incorporation incorporation or Bylaws by: bylaws by (i) facsimile telecommunication to the facsimile number provided below (or to any other facsimile number for the undersigned in the Company’s records); , (ii) electronic mail to the electronic mail address provided below (or to any other electronic mail address for the undersigned in the Company’s records); , (iii) posting on an electronic network together with separate notice to the undersigned of such specific posting; posting or (iv) any other form of electronic transmission (as defined in the Delaware General Corporation Law) directed to the undersigned. This consent may be revoked by the undersigned by written notice to the Company and may be deemed revoked in the circumstances specified in Delaware General Corporation Law § §232. (Print name of the warrant holder) (Signature) (Name and title of signatory, if applicable) (Date) (Fax number) (Email address) (Signature Page to the Notice of Exercise) EXHIBIT A-l A-1 INVESTMENT REPRESENTATION STATEMENT AND MARKET STAND-OFF AGREEMENT INVESTOR: _____________________________________________ COMPANY: IRHYTHM TECHNOLOGIESQ Holdings, INC. Inc SECURITIES: THE WARRANT ISSUED ON NOVEMBER 1AUGUST 30, 2012 2011, AS AMENDED (THE “WARRANT”) AND THE SECURITIES ISSUED OR ISSUABLE UPON EXERCISE THEREOF (INCLUDING UPON SUBSEQUENT CONVERSION OF THOSE SECURITIES) DATE: ____________________________ In connection with the purchase or acquisition of the above-listed Securities, the undersigned Investor represents and warrants to, and agrees with, the Company as follows:
Appears in 1 contract
